TY - JOUR
T1 - Effect of aspirin on the fibrinolytic response in perfused rat hindquarters
AU - Iacoviello, Licia
AU - De Curtis, Amalia
AU - Amore, Concetta
AU - D'Adamo, Maria Cristina
AU - Buczko, Wlodzimierz
AU - de Gaetano, Giovanni
AU - Donati, Maria Benedetta
PY - 1992/12/8
Y1 - 1992/12/8
N2 - The role of aspirin in tissue plasminogen activator (t-PA) release was studied in rats after experimental venous occlusion. For this purpose, we developed a new experimental model which combines a vascular perfusion system (isolated rat hindquarters) with vascular stimulation, namely the application of venous stasis. Application of venous stasis for 30 min induced the release of t-PA from the vascular endothelium into the perfusate (from 0.19 ± 0.05 to 0.39 ± 0.05 UI/ml), reaching a peak 90 s after reperfusion. Aspirin administered to rats 60 min before the experiments (100 mg/kg i.v.), or dissolved in Tyrode solution (100 μM), suppressed 6-keto-prostaglandin F1α (6-keto-PGF1α) synthesis (0.38 ± 0.09 in control and
AB - The role of aspirin in tissue plasminogen activator (t-PA) release was studied in rats after experimental venous occlusion. For this purpose, we developed a new experimental model which combines a vascular perfusion system (isolated rat hindquarters) with vascular stimulation, namely the application of venous stasis. Application of venous stasis for 30 min induced the release of t-PA from the vascular endothelium into the perfusate (from 0.19 ± 0.05 to 0.39 ± 0.05 UI/ml), reaching a peak 90 s after reperfusion. Aspirin administered to rats 60 min before the experiments (100 mg/kg i.v.), or dissolved in Tyrode solution (100 μM), suppressed 6-keto-prostaglandin F1α (6-keto-PGF1α) synthesis (0.38 ± 0.09 in control and
KW - Aspirin
KW - Fibrinolytic activity
KW - Venous stasis
UR - http://www.scopus.com/inward/record.url?scp=0026526457&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026526457&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(92)90283-A
DO - 10.1016/0014-2999(92)90283-A
M3 - Article
C2 - 1473562
AN - SCOPUS:0026526457
SN - 0014-2999
VL - 229
SP - 39
EP - 44
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1
ER -